English
MILESTONE SCIENTIFIC INC.
EDGAR149 filing records in this dataset, filed from 1996-08-14 to 2026-09-08. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 1.2 million USD Source
Exact value
1200000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 88.8 million shares Source
Exact value
88756989 shares
Reported share-count change
12.98% · 10.2 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-09-08.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 7 of 11 periods available· newest 2025-12-31
- Net income: 7 of 11 periods available· newest 2025-12-31
- Operating cash flow: 7 of 11 periods available· newest 2025-12-31
- Capital expenditure: 6 of 11 periods available· newest 2025-12-31
- Total assets: 7 of 11 periods available· newest 2025-12-31
- Total liabilities: 6 of 11 periods available· newest 2025-12-31
- Current assets: 7 of 11 periods available· newest 2025-12-31
- Current liabilities: 6 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 7 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 1.01 millionPrior period
−USD 4.71 million
–
Current period
−USD 5.72 million
–
Exact inputs and evidence
-5722216 − -4713597 = -1008619 USD
-4713597 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-5722216 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
USD 0Prior period
−USD 2.9 million
–
Current period
−USD 2.9 million
–
Exact inputs and evidence
-2900000 − -2900000 = 0 USD
-2900000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-2900000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+49.4%Prior period
USD 10,124
–
Current period
USD 15,124
–
Exact inputs and evidence
15124 − 10124 = 5000 USD
10124 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source15124 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | −USD 5.47 million Exact valueExact value: -5467522 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.95 million Exact valueExact value: -2946338 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 67,581 Exact valueExact value: 67581 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.01 million Calculation and evidence-2946338 − 67581 USD Exact free cash flow: -3013919 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 7.3 million Exact valueExact value: -7300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.98 million Exact valueExact value: -6984928 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 21,438 Exact valueExact value: 21438 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.01 million Calculation and evidence-6984928 − 21438 USD Exact free cash flow: -7006366 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 6.82 million Exact valueExact value: -6818317 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.03 million Exact valueExact value: -4033664 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 15,189 Exact valueExact value: 15189 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.05 million Calculation and evidence-4033664 − 15189 USD Exact free cash flow: -4048853 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 8.71 million Exact valueExact value: -8706131 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6 million Exact valueExact value: -6000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8,527 Exact valueExact value: 8527 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.01 million Calculation and evidence-6000000 − 8527 USD Exact free cash flow: -6008527 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 6.93 million Exact valueExact value: -6929104 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.3 million Exact valueExact value: -5300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 4.71 million Exact valueExact value: -4713597 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.9 million Exact valueExact value: -2900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 10,124 Exact valueExact value: 10124 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.91 million Calculation and evidence-2900000 − 10124 USD Exact free cash flow: -2910124 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 5.72 million Exact valueExact value: -5722216 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.9 million Exact valueExact value: -2900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 15,124 Exact valueExact value: 15124 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.92 million Calculation and evidence-2900000 − 15124 USD Exact free cash flow: -2915124 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
149 filings · 4,442 latest values · 4,442 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000855683, 855683, MLSS, edgar:855683, mlss
Also known as MILESTONE SCIENTIFIC INC., MILESTONE SCIENTIFIC INC/NJ, Milestone Scientific Inc., U S OPPORTUNITY SEARCH INC